86618.HK · JD HEALTH-R
Hong Kong · RS rating 41 · As of 2026-10-14
| Price | 31.66 HKD |
|---|---|
| 1-day change | +2.9% |
| RS rating (overall / 1M / 3M / 12M) | 41 / 82 / 47 / 23 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 21 / 21 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +50.1% |
| Market cap (USD) | – |